|
Bisphosphonates and Cancer Patients
Written By:
Paulette Campbell RN-BC, BSN, MJ
Certified Legal Nurse Consultant
Bisphosphonates are anti-resorption medications. They slow or stop the natural process that dissolves bone tissue. The goal is to maintain bone density and strength. This then prevents osteoporosis. This class of drug is prescribed to prevent or treat osteopenia or osteoporosis. There are 28 million Americans who suffer from osteoporosis. Bisphosphonates are also prescribed to treat other bone diseases such as Paget’s disease. Two of the most common bisphosphonates are alendronate (Fosamax) and risedronate (Actonel).
Cancer patients are prescribed bisphosphonates most often when their cancer has metastasized to the bone. In these circumstances cancer patients take bisphosphonates for the prevention of fractures due to bone metastases. When this treatment is successful it is beneficial because bone regeneration occurs constantly and cancer cells that spread to the bone can interfere with the regeneration and cause pain/discomfort to patients.
If you have a case involving bisphosphonates contact us today. Our medical legal consulting services will offer your firm a variety of effective solutions. From medical chart organization to medical case summary, you will find that we have the right solutions at the right time, for you. You can reach us at 630-551-0978 or info@medicaljurisprudence.com. |